Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.

McLerran D, Grizzle WE, Feng Z, Bigbee WL, Banez LL, Cazares LH, Chan DW, Diaz J, Izbicka E, Kagan J, Malehorn DE, Malik G, Oelschlager D, Partin A, Randolph T, Rosenzweig N, Srivastava S, Srivastava S, Thompson IM, Thornquist M, Troyer D, Yasui Y, Zhang Z, Zhu L, Semmes OJ.

Clin Chem. 2008 Jan;54(1):44-52. Epub 2007 Nov 2.

2.

Proteomics in diagnosis of prostate cancer.

Davalieva K, Polenakovic M.

Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015;36(1):5-36. Review.

PMID:
26076772
3.

MALDI mass spectrometry in prostate cancer biomarker discovery.

Flatley B, Malone P, Cramer R.

Biochim Biophys Acta. 2014 May;1844(5):940-9. doi: 10.1016/j.bbapap.2013.06.015. Epub 2013 Jul 2. Review.

PMID:
23831156
4.

The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology.

Grizzle WE, Semmes OJ, Basler J, Izbicka E, Feng Z, Kagan J, Adam BL, Troyer D, Srivastava S, Thornquist M, Zhang Z, Thompson IM.

Urol Oncol. 2004 Jul-Aug;22(4):337-43. Review.

PMID:
15283893
5.

[Surface enhanced laser desorption/ionization (SELDI): proteomics technology and its application in oncology].

Espejel F, Roa JC.

Med Clin (Barc). 2008 Sep 13;131(8):312-7. Review. Spanish.

PMID:
18803927

Supplemental Content

Support Center